Advisory Board and Editors Mass Spectrometry

Journal Factsheet
A one-page PDF to help when considering journal options with co-authors
Download Factsheet
I told my colleagues that PeerJ is a journal where they need to publish if they want their paper to be published quickly and with the strict peer review expected from a good journal.
Sohath Vanegas,
PeerJ Author
View author feedback

Julia Martín

Julia Martín obtained her Ph.D. in Chemistry in 2012 at University of Seville (Spain). She is Assistant Professor in the Department of Analytical Chemistry (University of Seville) since 2013. Her principal research interests fall into the three interrelated areas of environmental, analytical and water sciences. She is particularly interested in the development of new methodologies for the determination of majority and emerging pollutants in environmental and biological matrices. These methodologies are then applied to evaluate the occurrence and fate of pollutants to obtain information about their potential toxicological effects to the ecosystems. Her interest is also focused on the history of chemistry and on the methodological aspects of analytical science. She is a co-author of more than 50 publications in peer-reviewed journals, 20 book chapters, H-index 18 and 875 citation.

Nicolas Mazzella

My work focuses on analytical chemistry with the development of methods for the analysis of organic micropollutants. I am also interested in passive sampling techniques to characterise the exposure of aquatic organisms (microalgae, biofilms).

In addition, I am carrying out analytical developments in the field of lipidomics to propose biomarkers of toxic effects in aquatic plants and marine or freshwater fish.

Ralph Mead

I am an organic geochemist studying the fate and transport of anthropogenically and natural derived organic compounds in the Anthropocene.

Biswapriya Biswavas Misra

Interested in metabolomics and genomics of diseases! My current work is focused on generating quality metabolomics datasets leveraging the high-resolution mass-spectrometry (GC-Orbitrap-MS and LC-Orbitrap-MS) and occasionally NMR datasets to combine with other -omics layers such as genomics (transcriptomics, epigenetics), proteomics, and clinical data sets to provide insights in metabolic changes that are associated with human and non-human primate wellness and disease conditions, specifically metabolic syndromes such as atherosclerosis, diabetes, obesity, and Alzheimer’s disease.

Ravindra K. Rawal

Dr. Ravindra K. Rawal is a Professor of Chemistry at Maharishi Markandeshwar (Deemed to be University), Mullana (Haryana). Professor & Head at ISF College of Pharmacy, Moga. Postdoctoral Associate with Distinguished Prof. C.K. Chu’s Drug Discovery group in the College of Pharmacy, University of Georgia, USA. Postdoctoral Research Fellow with Prof. Don J. Diamond in the virology division of Beckman Research Institute, City of Hope, USA.

Mirela Sedic

Dr Mirela Sedic (born Bauman) is Principal Scientist at the Institute for Anthropological Research Zagreb. She has authored over 50 scientific publications in peer-reviewed journals including high-impact journals such as BBA Molecular Basis of Disease, Molecular Cancer, The Journal of Pathology, Molecular Cancer Therapeutics, Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry and Cancer Treatment Reviews.

She was the co-PI of international collaborative project with Functional Genomics Center Zurich in Switzerland (PRIME-XS-0000184 Proteomic profiling of retinal proteins from rat model of age-related macular degeneration 2012-2014) and the PI of the University of Rijeka grant “Screening and biological evaluation of acid ceramidase and sphingosine kinase inhibitors as a new class of anti-tumour agents” (2014 – 2017). She is currently the PI of the project funded by the Croatian Science Foundation “Dissecting the mechanisms of therapy resistance in BRAF-mutant colon cancer using an integrated –omics approach” (2019 – 2023) and the PI of the University of Rijeka research grant “Molecular features associated with BRAFV600E-mutated versus wild type BRAF colorectal cancer” (2019-2022). She is also the PI of the project No. 3238 - EPIC-XS 012: “Proteomic analysis of acquired resistance to vemurafenib in BRAF V600E–mutant colon cancer cells” (2019 - 2022) in collaboration with the Functional Genomics Center Zurich in Switzerland.

Pawel L Urban

Pawel L. Urban received his MSc degree in biology from the University of Warsaw in 2002, and PhD degree in chemistry from the University of York in 2008. He conducted research stays in the University of Alcala, University of Warsaw, and ETH Zurich. The Urban’s laboratory was initially located in the National Chiao Tung University; then moved to the National Tsing Hua University. The team focuses on the development of enabling technologies for chemistry research and clinical analysis, their applications, as well as fundamental studies.

Robert Winkler

Robert Winkler is Principal Investigator of the Laboratory of Biochemical and Instrumental Analysis at the CINVESTAV Unidad Irapuato and faculty member for the postgraduate programs Plant Biotechnology and Integrative Biology. His research topics include novel mass spectrometry techniques such as low-temperature plasma ionization and covalent protein staining, new approaches in the high-throughput metabolomic profiling of plants, computational mass spectrometry and proteomics.